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Abstract 
Objective : Ten percent of adults presenting with iron deficiency anaemia (IDA) have 
underlying cancer. This study was undertaken to assess whether five simple clinical 
parameters can usefully predict the likelihood of gastrointestinal (GI) malignancy on 
subsequent investigation of patients with IDA.  
Design : Retrospective observational study, with multivariable analysis of the predictive 
value of sex, age, haemoglobin concentration (Hb), mean red cell volume (MCV) and iron 
studies for the risk of underlying GI malignancy. 
Setting : District General Hospital IDA clinic. 
Patients : 720 adults with confirmed IDA. 
Results : Sex, age, and Hb were strongly associated with the risk of GI malignancy - the 
parsimonious model including only these variables yielded odds ratios of 4.0 (95% 
confidence interval (CI): 2.3, 7.0) for males compared to females; 3.3 (95% CI: 1.7, 6.4) for 
age > 70 years compared to ≤70 years; and 5.3 (95% CI: 2.4, 11.7) for an Hb of ≤91.4g/l 
compared to ≥111.5g/l. Combining these risk factors identified a sub-group (12% of the 
study population) at particularly low risk (<2% likelihood), and a second sub-group (16% 
of the study population) at especially high risk (>20% likelihood) of underlying GI 
malignancy.   
Conclusions : Three simple and objective clinical parameters can be combined to provide 
a clinically useful cancer risk stratification model for subjects with IDA. This may assist 
with patient counselling and the prioritization of investigational resources. 
 
  
Introduction 
IDA is a common clinical problem. In adult males or post-menopausal females, about 30% 
of subjects overall will have underlying GI pathology. Malignancy accounts for about a 
third of these, about 10% of the total, often in the absence of localising symptoms 1-4.  
The IDA clinic at Poole Hospital has been operational since 2004, and is the point of 
referral for patients with IDA who have minimal or no symptoms to indicate the nature or 
location of the underlying cause of iron deficiency 5. Basic patient data have been 
collected since inception, for the purposes of clinical care, audit and service evaluation. 
The register now exceeds 1000 subjects.  
It is inherently unlikely that all subjects with IDA will have the same pre-test probability 
of malignancy, but without the tools to predict individual risk it is currently standard 
practice to recommend urgent investigation for IDA on the grounds that there might be an 
underlying malignancy 6. A simple but reliable pre-test predictor of risk would help 
considerably with patient counselling. It could also facilitate better use of resources, with 
prioritisation of high-risk subjects for fast track investigation, and perhaps avoidance of 
investigation in particularly low risk individuals. 
 
 
Method 
The aim of the study was to determine whether simple and objective clinical parameters 
could usefully identify sub-groups of patients with IDA at particularly high and low risk of 
underlying malignancy of the GI tract. Given an overall prevalence of GI malignancy of 
about 10% in this patient population, it was decided – on a purely arbitrary basis - that 
identifying a low-risk sub-group with a cancer risk of < 2%, and / or a high-risk sub-group 
with a cancer risk of > 20%, might prove useful in clinical practice.  
The study involved a retrospective analysis of clinical data for subjects on the Poole IDA 
clinic register assessed between June 2004 and May 2012 inclusive, who went on to have 
GI investigation and for whom information on the final diagnosis was available. 
Anonymised data were analysed using Predictive Analytics Software (PASW) to assess 
whether five clinical parameters  – sex, age, Hb, MCV and iron studies – could usefully 
predict the likelihood of GI pathology, and in particular malignancy, on subsequent 
investigation.  Having viewed the protocol, the National Research Ethics Service advised 
that formal Research Ethics Committee approval was not required. 
Age was categorised as a dichotomous variable (70 or less versus over 70 years), as the 
incidence of the major GI malignancies rises steeply after this age. An initial examination 
of the data revealed a striking step-wise increment in the prevalence of underlying cancer 
at around the age of 70 – rising from 2.6% in the 60-69 age-group, to 11.6% in the 70-79 
age-group. Hb and MCV were analysed as study population quartiles in order to obtain 
approximately equally sized groups, since there is no accepted way of categorising these 
variables - the quartiles are presented in order of increasing anaemia and microcytosis 
respectively. Dichotomous outcome variables were created to indicate a diagnosis of 
malignant neoplasm, benign neoplasm over 1cm in diameter (smaller lesions were felt 
unlikely to have made a significant contribution to the development of IDA), inflammatory 
disorder, vascular malformation or coeliac disease. A further outcome variable was 
created based on whether subjects had any of the above diagnoses.   
Data sets were complete for sex, age, Hb, MCV and final diagnosis. Results for iron studies 
– transferrin saturation or serum ferritin or both – were available for 90% of the study 
population. The major reason for the absence of data for the remaining 10% was that iron 
supplements had been commenced prior to referral, without the relevant test being 
requested. Iron deficiency was therefore analysed as a dichotomous variable, being 
“severe” (arbitrarily defined as a transferrin saturation <10%, a serum ferritin <10ug/l or 
both) or “non-severe” (criteria for severe deficiency not met).  
Frequencies were run to provide descriptive information for the study population. 
Logistic regressions were used to investigate the associations with each explanatory 
variable on their own to obtain odds ratios, and together to adjust for all the other 
demographic and clinical characteristics. The parsimonious model was then selected for 
malignant neoplasm including only the factors that were significant (using a significance 
level of 5%) and 95% CIs were presented. The Nagelkerke R Square was used to assess 
the proportion of variance explained in the data i.e. a measure of how well the models 
fitted the data. 
 
 
 
Results  
Almost 1000 subjects were seen in the IDA clinic during the study period. Having 
excluded those in whom iron deficiency was not confirmed, or where investigations were 
not completed due to patient preference, frailty or concurrent illness, data for 720 
subjects were analysed. The study group comprised 433 females and 287 males, with a 
median age of 75 years (inter-quartile range 62 - 82 years). Of these, 219 (30.4%) were 
found on investigation to have at least one GI diagnosis considered to be clinically 
significant, and 68 (9.4%) had a GI malignancy. 
Colorectal cancer accounted for 52/68 (76%) of the GI malignancies identified. Other 
underlying GI diagnoses in the study population were inflammatory disorders in 80 
(11.1%), coeliac disease in 34 (4.7%), vascular malformations in 34 (4.7%) and benign 
neoplasia in 21 (2.9%). Some subjects had more than one diagnosis. 
As shown in Table 1, male sex, age > 70 years, and severity of anaemia were all 
significantly associated with an increased risk of underlying GI malignancy on univariate 
analysis. Male sex and age > 70 years were also significantly associated with an increased 
risk of “any underlying GI diagnosis” but the relationships were not so strong, and the link 
with GI malignancy appeared to be driving these associations.  
 
Table 1  Odds ratios and significance levels for the associations between clinical 
characteristics and the outcomes of (a) gastrointestinal malignancy, and (b) any 
gastrointestinal diagnosis, in 720 subjects with iron deficiency anaemia, Poole 
Hospital 2004 – 2012 
 
 
Q - quartile; RC - reference category; p-values are based on logistic regression,  
  with each variable added individually 
  
Variable 
Percent (n) with 
GI malignancy 
Odds ratio 
(p-value) 
Percent (n) 
with any GI 
diagnosis 
Odds ratio 
(p-value) 
Sex     
  Female 5.1 (22) RC 24.7 (107) RC 
  Male 16.0 (46) 3.6 (<0.001) 39.0 (112) 2.0 (<0.001) 
     
Age / years     
  ≤70 4.2 (12) RC 24.8 (71) RC 
  >70 12.9 (56) 3.4 (<0.001) 34.1 (148) 1.6 (0.008) 
     
Haemoglobin / g/l  (<0.001)  (0.090) 
  Q1 : ≥111.5 5.2 (9) RC 28.2 (49) RC 
  Q2 : 102.5 – 111.4 5.6 (10) 1.1 (0.863) 27.4 (49) 1.0 (0.869) 
  Q3 : 91.5 – 102.4 9.1 (16) 1.8 (0.160) 27.8 (49) 1.0 (0.947) 
  Q4 : ≤91.4 17.3 (33) 3.8 (0.001) 37.7 (72) 1.5 (0.054) 
       
     
Mean red cell volume / fl  (0.114)  (0.126) 
  Q1 : >84.3 6.8 (12) RC 26.6 (47) RC 
  Q2 :  77.8 – 84.3 9.3 (17) 1.4 (0.383) 33.3 (61) 1.4 (0.161) 
  Q3 :  72.5 – 77.8 7.6 (13) 1.1 (0.755) 25.9 (44) 1.0 (0.887) 
  Q4 : <72.5 13.7 (26) 2.2 (0.033) 35.3 (67) 1.5 (0.072) 
     
     
Iron deficiency - severe     
  No 8.5 (18) RC 29.7 (63) RC 
  Yes 8.7 (38) 1.0 (0.924) 28.7 (125) 1.0 (0.783) 
On logistic regression analysis with adjustment for other variables, sex, age and Hb 
remained significant independent predictors of the probability of underlying GI 
malignancy. Table 2 presents the results from the parsimonious model including only 
these variables. Men were four times more likely to be diagnosed with a GI malignancy 
than women, and subjects over 70 years old were three times more likely than those ≤ 70 
years.  Those with a an Hb of 91.5-102.4g/l were two and half times more likely, and 
those with an Hb of ≤91.4g/l were five times more likely to be diagnosed with a GI 
malignancy than those with an Hb of ≥111.5g/l.  
 
 
Table 2  Odds ratios with 95% confidence intervals (CI) and p-values for parsimonious 
logistic regression model of clinical variables associated with gastrointestinal 
malignancy, in 720 subjects with iron deficiency anaemia, Poole Hospital 2004 – 
2012 
 
Variable 
Number of 
subjects 
Odds ratio 
(95% CI) 
p-value 
Sex    
  Female 433 RC  
  Male 287 4.0 (2.3, 7.0) <0.001 
    
Age / years    
  ≤70 286 RC  
  >70 434 3.3 (1.7, 6.4) <0.001 
    
Haemoglobin / g/l   <0.001 
  Q1 : ≥111.5 174 RC  
  Q2 : 102.5 – 111.4 179 1.6 (0.6, 4.3) 0.307 
  Q3 : 91.5 – 102.4 176 2.5 (1.1, 6.1) 0.037 
  Q4 : ≤91.4 191 5.3 (2.4, 11.7) <0.001 
      
 
RC = reference category; Q = quartile; p-values based on logistic regression, 
 adjusting for the three variables  
 
 
  
Combining the three predictive clinical variables provided a stronger indicator of the 
likelihood of GI malignancy than when considered in isolation. Individually these three 
variables accounted for 5 to 7% of the variance in the data, whilst collectively they 
explained 18%. Broadly, there was an incremental increase in risk with increasing degree 
of anaemia within each of the four age/sex sub-groups. The risk was generally greater for 
males than for females of the same age-group and haemoglobin quartile (Figure 1). 
 
[Figure 1 about here] 
 
 
The combination of the three clinical risk factors identified patient sub-groups at the two 
ends of the spectrum of risk of underlying GI malignancy – those with cancer likelihoods 
exceeding the arbitrary thresholds of <2% and >20%. Specifically, younger females with 
mild anaemia (accounting for 12% of the study population) were at particularly low risk, 
whilst males with more severe anaemia (accounting for 16% of the study population) 
were at especially high risk of underlying gastrointestinal malignancy (Table 3). 
 
 
Table 3  The percentage prevalence (with 95% confidence intervals) of gastrointestinal 
malignancy in 16 sub-groups by sex, age and haemoglobin quartile of 720 subjects 
with iron deficiency anaemia, Poole Hospital 2004-2012 
  
Q = quartile; lower figures in each box indicate the number of cancers / 
number of subjects in each sub-group 
 
Haemoglobin /g/l 
Female 
 ≤70 years 
Female 
 >70 years 
Male 
 ≤70 years 
Male 
 >70 years 
  Q1 : ≥111.5 
0.0 (0.0, 10.2) 
0 / 34 
2.9 (0.5, 14.5) 
1 / 35 
2.4 (0.4, 12.3) 
1 / 42 
11.1 (5.5, 21.2) 
7 / 63 
  Q2 : 102.5 -111.4 
0.0 (0.0, 7.0) 
0 / 51 
3.8 (1.3, 10.7) 
3 / 78 
5.3 (0.9, 24.6) 
1 / 19 
19.4 (9.2, 36.3) 
6 / 31 
  Q3 : 91.5 -102.4 
3.6 (1.0, 12.1) 
2 / 56 
7.7 (3.3, 16.8) 
5 / 65 
0.0 (0.0, 24.3) 
0 / 12 
20.9 (11.4, 35.2) 
9 / 43 
  Q4 : ≤91.4 
2.4 (0.4, 12.6) 
1 / 41 
13.7 (7.6, 23.4) 
10 / 73 
22.6 (11.4, 39.8) 
7 / 31 
32.6 (20.9, 47.0) 
15 / 46 
Discussion 
IDA is a problem that is commonly encountered in current clinical practice 1-4. Our recent 
experience would suggest an increasing overall incidence that now approaches 1 case 
diagnosed per 1000 population per annum 5. The age-specific incidence of IDA in the 
elderly is considerably higher than this, and it is noteworthy that the median age of the 
study population was 75 years. This may of course reflect enhanced ascertainment due to 
the escalating number of requests for routine blood count estimations, particularly in the 
elderly. 
Several mechanisms underlie the development of IDA, but the major categories are 
dietary insufficiency, malabsorption, and chronic low-grade haemorrhage from a mucosal 
surface. IDA in pre-menopausal females most commonly relates to dietary inadequacy 
and / or menstrual losses. However, about 30% of males and post-menopausal females 
however will prove to have significant underlying GI pathology, with malignancy 
accounting for about a third of these, often in the absence of clear clinical pointers to the 
diagnosis. Malignancy is undoubtedly the most important cause, and indeed it is the 
primary justification for the urgent investigation of subjects with IDA 1-6.  
Bidirectional endoscopy (BDE), combining gastroscopy and colonoscopy in the same 
session, is generally accepted as the most efficient method of assessing the GI tract in IDA 
unless there are clear clinical clues as to the cause 6.  BDE is labour-intensive however, 
taking up to an hour to complete for each patient. Furthermore, endoscopy carries a small 
but significant risk of complications, particularly in the elderly and those with major co-
morbidities.  
Given that over 90% of endoscopic examinations in individuals with IDA will fail to reveal 
a GI malignancy, it is obviously important to consider the risk-benefit ratio for 
investigation of IDA on an individual case basis. There is therefore a need for a simple and 
reliable pre-test predictor of the risk of underlying malignancy that is sufficiently 
discriminating to be clinically (and not just statistically) significant.  
To the authors’ knowledge, there are to date only three published multivariate analyses of 
variables predictive of the risk of GI malignancy in IDA 7-9. The findings are summarised in 
Table 4, along with those of the current study for comparison. There is universal 
agreement that age is a risk factor, but the findings for the other variables are somewhat 
discordant. However, two of the studies had a rather small sample size, and it is notable 
that the two largest studies are fully concordant for all five risk factors assessed. The 
findings from this current study confirm the results from the Nottingham study 9, 
identifying age, sex and Hb as independent variables predictive of underlying GI 
malignancy in IDA.  This conclusion fits well with the findings of a large study utilising 
electronic primary care records employing a case-control methodology, which correlated 
age and degree of anaemia with colorectal cancer risk 10. 
 
Table 4  Summary of published multivariate analyses of variables predictive of underlying 
gastrointestinal (GI) malignancy in subjects with iron deficiency anaemia 
 
 
Hb - haemoglobin; MCV - mean cell volume; Iron – iron studies 
IDIOM - present study; blank cell - not assessed 
 
The predictive value of age and sex is not unexpected, given that the incidence of the 
major GI malignancies rises steeply after the age of 70 years, particularly in males 11. It 
may simply be that Hb is predictive of cancer risk because the nature of the pathology 
means that GI malignancy is disproportionately more likely than the other (non-
malignant) causes of IDA to lead to greater degrees of anaemia. Why this is not reflected 
by the results of iron studies is less clear, though of course ferritin and transferrin 
saturation are surrogate markers of body iron stores, and may be influenced by other 
factors – serum ferritin in particular is an acute phase protein, and may therefore be 
spuriously high in individuals with malignancy.  
Given an overall probability of underlying GI malignancy of 10%, it was arbitrarily 
considered that identifying a low-risk sub-group with a cancer risk of less than 2%, and a 
high-risk sub-group with a cancer risk of greater than 20%, might be useful in clinical 
practice. The results suggest that over a quarter of subjects with IDA can be predicted to 
be of extremely low or high risk on the basis of these simple and objective clinical criteria. 
This may be of clinical relevance for patient counselling and prioritisation of 
investigations. It might also inform the decision as to whether to submit patients at 
extreme low risk to an invasive investigational strategy, though rigorous validation of the 
study results is essential before such a move can be contemplated.  
The findings are unlikely to be the result of referral bias. Younger women with mild 
anaemia are probably the sub-group least likely to be referred unless there was some 
other reason for suspecting GI disease, for example a positive family history of GI cancer. 
This might have been expected to result in a falsely high prevalence of GI malignancy in 
this sub-group, yet in the event the figure was 0%. 
Study n 
Percentage 
with GI 
malignancy 
Predictive variable 
Sex Age Hb MCV Iron 
Capurso (2004) 7 98 18.4 Yes Yes No Yes No 
Ho (2005) 8 148 12.2 No Yes No - Yes 
James (2005) 9 695 11.2 Yes Yes Yes No No 
IDIOM study (2013) 720 9.4 Yes Yes Yes No No 
The study presented was retrospective and exploratory, carrying the inevitable issues 
associated with multiple significance testing. The limitations of multivariate analysis are 
also well established 12.  Further work is clearly required to validate prospectively the 
predictive value of the risk factors identified, and this is underway. The results to date 
represent a first cut, utilising simple clinical information available from our IDA register. 
It is possible that additional clinical or laboratory variables could be added to improve the 
discriminatory capacity of the model still further - for example a family history of GI 
malignancy, the use of aspirin, or faecal occult blood testing - and this avenue is also being 
explored.  
In conclusion this study has extended previous observations, confirming that sex, age, and 
Hb are strong and independent predictors of the risk of underlying GI malignancy in 
subjects with IDA. It has also demonstrated that in combination these variables can 
identify over 25% of the study population who are at particularly high or low risk. The 
incremental nature of the model lends itself to the development of a simple scoring 
system for malignancy risk stratification that could be of practical value in a clinical 
setting.   
 
 
Figure 1  The percentage prevalence of gastrointestinal malignancy in 16 sub-groups by 
sex, age and haemoglobin quartile of 720 patients with iron deficiency anaemia, 
Poole Hospital 2004-2012 
[Figure 1]  Haemoglobin quartile ranges are as in Tables 1 - 3, and the prevalence figures 
are based on raw data. 
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